<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    May 11, 2012

    Collaboration as the key to turning around the drug discovery business (Part 11) - The future

    The Future of Collaborative Drug Discovery

    the future

    The prerequisite to enable the efficiencies of integrated specialization, are secure, trusted collaborative platforms.  Mechanisms are required that balance allowing maximum collective contributions, with maximum control of intellectual property ownership.

    Fortunately, technologies are emerging in this area to allow what was previously impossible, to become routine.  Platforms like LinkedIn and Facebook, with rich, flexible privacy and sharing controls, give us insight into the collective efficiencies that are now just within our grasp.

     

     


    For full context, find the link to each entry of our 12-part series, "Collaboration is the Key to Turning Around the Drug Discovery Business" using the links below:

    Read Part 1: Collaboration as the key for turning around the drug discovery business – The Problem

    Read Part 2: Collaboration as the key for turning around the drug discovery business – The Hypothesis

    Read Part 3: Collaboration as the key for turning around the drug discovery business – A Solution

    Read Part 4: Collaboration as the key to turning around the drug discovery business – Collaboration and Innovation

    Read Part 5: Collaboration as the key to turning around the drug discovery business - A Monte Carlo Simulation

    Read Part 6: Collaboration as the key to turning around the drug discovery business - Technology can Make Things Easier

    Read Part 7: Collaboration as the key to turning around the drug discovery business: Collaboration = Leverage

    Read Part 8: Collaboration as the key to turning around the drug discovery business – Standards

    Especially read Part 9:  Collaboration as the key to turning around the drug discovery business - Collaborate Better

    Part 10:  Collaboration as the key to turning around the drug discovery business - Learning from eBay, NASDAQ, Airlines, & Hollywood

    Part 11: Collaborative as the key to turning around the drug discovery business - The Future

    Part 12: Collaboration as the key to turning around the drug discovery business

    P.S. Beyond collaboration as a more enlightened approach to science, here are the top 5 practical reasons collaborative scientists rock with CDD: 5 Reasons Why Collaborative Scientists Use CDD

    You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document:

    full-series


    This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registrationstructure activity relationshipchemical inventory, and electronic lab notebook capabilities!

    CDD Vault: Drug Discovery Informatics your whole project team will embrace!

    Other posts you might be interested in

    View All Posts
    CDD Blog
    9 min   March 26, 2024
    Drug Discovery Industry Roundup with Barry Bunin — March 26, 2024
    Read More
    CDD Blog
    2 min   March 26, 2024
    Recorded Webinar: Trends & Better Practices for the Use of Gen AI & LLMs
    Read More
    CDD Blog
    2 min   March 22, 2024
    Recorded Webinar: Interdisciplinary Pathways in Medicine- from Neurodegenerative to Oncology Disease Research and Drug Discovery
    Read More